Hide metadata

dc.date.accessioned2024-03-10T18:51:03Z
dc.date.available2024-03-10T18:51:03Z
dc.date.created2023-11-06T17:05:29Z
dc.date.issued2023
dc.identifier.citationSandoz, Patrick A. Kuhnigk, Kyra Szabo, Edina Krisztina Thunberg, Sarah Erikson, Elina Sandström, Niklas Verron, Quentin Brech, Andreas Watzl, Carsten Wagner, Arnika K. Alici, Evren Malmberg, Karl-Johan Uhlin, Michael Önfelt, Björn . Modulation of lytic molecules restrain serial killing in γδ T lymphocytes. Nature Communications. 2023, 14(1)
dc.identifier.urihttp://hdl.handle.net/10852/109421
dc.description.abstractAbstract γδ T cells play a pivotal role in protection against various types of infections and tumours, from early childhood on and throughout life. They consist of several subsets characterised by adaptive and innate-like functions, with Vγ9Vδ2 being the largest subset in human peripheral blood. Although these cells show signs of cytotoxicity, their modus operandi remains poorly understood. Here we explore, using live single-cell imaging, the cytotoxic functions of γδ T cells upon interactions with tumour target cells with high temporal and spatial resolution. While γδ T cell killing is dominated by degranulation, the availability of lytic molecules appears tightly regulated in time and space. In particular, the limited co-occurrence of granzyme B and perforin restrains serial killing of tumour cells by γδ T cells. Thus, our data provide new insights into the cytotoxic arsenal and functions of γδ T cells, which may guide the development of more efficient γδ T cell based adoptive immunotherapies.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleModulation of lytic molecules restrain serial killing in γδ T lymphocytes
dc.title.alternativeENEngelskEnglishModulation of lytic molecules restrain serial killing in γδ T lymphocytes
dc.typeJournal article
dc.creator.authorSandoz, Patrick A.
dc.creator.authorKuhnigk, Kyra
dc.creator.authorSzabo, Edina Krisztina
dc.creator.authorThunberg, Sarah
dc.creator.authorErikson, Elina
dc.creator.authorSandström, Niklas
dc.creator.authorVerron, Quentin
dc.creator.authorBrech, Andreas
dc.creator.authorWatzl, Carsten
dc.creator.authorWagner, Arnika K.
dc.creator.authorAlici, Evren
dc.creator.authorMalmberg, Karl-Johan
dc.creator.authorUhlin, Michael
dc.creator.authorÖnfelt, Björn
cristin.unitcode185,53,2,18
cristin.unitnamePRIMA - Senter for presisjons-immunterapi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.cristin2192873
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Nature Communications&rft.volume=14&rft.spage=&rft.date=2023
dc.identifier.jtitleNature Communications
dc.identifier.volume14
dc.identifier.issue1
dc.identifier.pagecount0
dc.identifier.doihttps://doi.org/10.1038/s41467-023-41634-7
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2041-1723
dc.type.versionPublishedVersion
cristin.articleid6035
dc.relation.projectNFR/332727


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International